NCT05482100View on ClinicalTrials.gov

CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions

Kidney Transplant Rejection

Interventions

DIAGNOSTIC_TEST

Patients monitored with OmniGraf testing

This is an observational study there are no protocol mandated interventions. OmniGraf results will be utilized in conjunction with standard of care assessments to determine patient management.

All Listed Sponsors

lead

Transplant Genomics, Inc.

INDUSTRY

NCT05482100 - CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients | Biotech Hunter | Biotech Hunter